The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 24, 2015

Filed:

Nov. 13, 2012
Applicant:

Jennerex, Inc., San Francisco, CA (US);

Inventors:

David Kirn, Mill Valley, CA (US);

Steve H. Thorne, Palo Alto, CA (US);

Assignee:

Sillajen Biotherapeutics, Inc., San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/275 (2006.01); C12N 7/00 (2006.01); C12N 15/86 (2006.01); A61K 38/21 (2006.01); A61K 45/06 (2006.01); C12N 7/01 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/768 (2013.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); A61K 48/00 (2013.01); C12N 2710/24121 (2013.01); C12N 2710/24132 (2013.01); C12N 2710/24143 (2013.01); C12N 2710/24161 (2013.01); C12N 2710/24162 (2013.01);
Abstract

The present invention concerns methods and compositions for the treatment of cancer and cancer cells using altered poxviruses, including a vaccinia virus that has been altered to generate a more effective therapeutic agent. Such poxviruses are engineered to be attenuated or weakened in their ability to affect normal cells. In some embodiments, methods and compositions involve poxviruses that possess mutations that result in poxviruses with diminished or eliminated capability to implement an antiviral response in a host. Poxviruses with these mutations in combination with other mutations can be employed for more effective treatment of cancer.


Find Patent Forward Citations

Loading…